HELPING THE OTHERS REALIZE THE ADVANTAGES OF MBL77

Not all patients with CLL require therapy. In spite of all new advances, the iwCLL nonetheless endorses watchful observation for patients with asymptomatic condition.86 This recommendation is based on a minimum of two randomized trials comparing observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).This d